QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dmd.108.023242v1 36/12/2460    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sakuyama, K. Articles by Hiratsuka, M. Search for Related Content PubMed PubMed Citation Articles by Sakuyama, K. Articles by Hiratsuka, M.

Functional Characterization of 17 CYP2D6 Allelic Variants (CYP2D6.2, 10, 14A–B, 18, 27, 36, 39, 47–51, 53–55, and 57)

Department of Clinical Pharmacotherapeutics, Tohoku Pharmaceutical University, Sendai, Japan (K.S., T.S., S.U., K.O., M.I., M.H.); and Department of Clinical Pharmaceutics, Tohoku Pharmaceutical University, Sendai, Japan (M.M.)

Cytochrome P450 2D6 (CYP2D6) is an enzyme of potential importance for the metabolism of drugs used clinically, and it exhibits genetic polymorphism with interindividual differences in metabolic activity. To date, 21 CYP2D6 allelic variants have been identified in the Japanese population. The aim of this study was to investigate the functional characterization of CYP2D6 variants identified in Japanese subjects. Wild-type CYP2D6 and its variants, namely, CYP2D6.2, CYP2D6.10, CYP2D6.14A, CYP2D6.14B, CYP2D6.18, CYP2D6.27, CYP2D6.36, CYP2D6.39, CYP2D6.47, CYP2D6.48, CYP2D6.49, CYP2D6.50, CYP2D6.51, CYP2D6.53, CYP2D6.54, CYP2D6.55, and CYP2D6.57 were transiently expressed in COS-7 cells, and enzymatic activities of the CYP2D6 variant proteins were characterized using bufuralol and dextromethorphan. Functional characterization of 17 CYP2D6 variants revealed an absence of enzyme activity in four (CYP2D6.14A, CYP2D6.36, CYP2D6.47, and CYP2D6.57), low activity in eight (CYP2D6.10, CYP2D6.14B, CYP2D6.18, CYP2D6.49, CYP2D6.50, CYP2D6.51, CYP2D6.54, and CYP2D6.55), and high activity in one (CYP2D6.53) compared with the wild type. Analysis of CYP2D6 variant proteins can be useful for predicting CYP2D6 phenotypes and could be applied to personalized drug therapy.

This article has been cited by other articles:

				S.-J. Lee, S. S. Lee, H.-J. Jung, H.-S. Kim, S.-J. Park, C.-W. Yeo, and J.-G. Shin Discovery of Novel Functional Variants and Extensive Evaluation of CYP2D6 Genetic Polymorphisms in Koreans Drug Metab. Dispos., July 1, 2009; 37(7): 1464 - 1470. [Abstract] [Full Text] [PDF]

				X.-L. Jiang, H.-W. Shen, and A.-M. Yu Pinoline May be Used as a Probe for CYP2D6 Activity Drug Metab. Dispos., March 1, 2009; 37(3): 443 - 446. [Abstract] [Full Text] [PDF]